These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17327330)

  • 1. Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance.
    Fernández-Real JM; Moreno JM; Chico B; López-Bermejo A; Ricart W
    Diabetes Care; 2007 Mar; 30(3):616-21. PubMed ID: 17327330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
    Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
    Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentration of visfatin in obese women.
    Zahorska-Markiewicz B; Olszanecka-Glinianowicz M; Janowska J; Kocełak P; Semik-Grabarczyk E; Holecki M; Dabrowski P; Skorupa A
    Metabolism; 2007 Aug; 56(8):1131-4. PubMed ID: 17618961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.
    Dogru T; Sonmez A; Tasci I; Bozoglu E; Yilmaz MI; Genc H; Erdem G; Gok M; Bingol N; Kilic S; Ozgurtas T; Bingol S
    Diabetes Res Clin Pract; 2007 Apr; 76(1):24-9. PubMed ID: 16956691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women.
    Chen CC; Li TC; Li CI; Liu CS; Lin WY; Wu MT; Lai MM; Lin CC
    Metabolism; 2007 Sep; 56(9):1216-20. PubMed ID: 17697864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
    Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol.
    Jin H; Jiang B; Tang J; Lu W; Wang W; Zhou L; Shang W; Li F; Ma Q; Yang Y; Chen M
    Diabetes Res Clin Pract; 2008 Mar; 79(3):412-8. PubMed ID: 18241953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance.
    Straczkowski M; Kowalska I; Nikolajuk A; Otziomek E; Adamska A; Karolczuk-Zarachowicz M; Gorska M
    Int J Obes (Lond); 2007 Feb; 31(2):221-5. PubMed ID: 16770329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
    Chang YC; Chang TJ; Lee WJ; Chuang LM
    Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visfatin, low-grade inflammation and body mass index (BMI).
    Samara A; Pfister M; Marie B; Visvikis-Siest S
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):568-74. PubMed ID: 18248642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
    Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
    Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating soluble transferrin receptor according to glucose tolerance status and insulin sensitivity.
    Fernández-Real JM; Moreno JM; López-Bermejo A; Chico B; Vendrell J; Ricart W
    Diabetes Care; 2007 Mar; 30(3):604-8. PubMed ID: 17327328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visfatin expression is elevated in normal human pregnancy.
    Morgan SA; Bringolf JB; Seidel ER
    Peptides; 2008 Aug; 29(8):1382-9. PubMed ID: 18524416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of visfatin and possible interaction with iron parameters in gestational diabetes mellitus.
    Kaygusuz I; Gumus II; Yılmaz S; Simavlı S; Uysal S; Derbent AU; Gözdemir E; Kafalı H
    Gynecol Obstet Invest; 2013; 75(3):203-9. PubMed ID: 23548246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.